US21900C3088
US21900C3088
CorMedix Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 575.23M EUR | 609.69M EUR | 532.3M EUR | 921.8M EUR |
Enterprise Value | 461.32M EUR | 498.14M EUR | 499.1M EUR | 925.88M EUR |
Valuation Multiples | ||||
Trailing P/E | 3.6x | 3.26x | 2.94x | 6.47x |
Forward P/E | 21.09x | -- | -- | -- |
Price to Sales | 1.24x | 1.33x | 1.33x | 3.38x |
Price to Book | 1.24x | 1.32x | 1.22x | 2.27x |
EV/Revenue | 1x | 1.08x | 1.25x | 3.4x |
EV/EBITDA | 1.76x | 1.87x | 2.18x | 6.3x |
Price to FCF (P/FCF) | 3.23x | 2.43x | 2.73x | 6.02x |
EV/FCF | 2.59x | 1.99x | 2.56x | 6.05x |
FCF Yield | 30.97% | 41.07% | 36.58% | 16.6% |